Herein, we provide evidence that endothelial FoxO1 is critical to the development of metabolic disorders in obesity through the converging actions of controlling metabolic activity and angiogenic fate of the endothelium. This evidence concerns the gene FOXO1 and obesity due to melanocortin 4 receptor deficiency.